Table 6.
Sporadic Alzheimer’s disease |
Familial Alzheimer’s disease |
|||||||
---|---|---|---|---|---|---|---|---|
Amyloid-β40 GuHCl |
Amyloid-β42 GuHCl |
Amyloid-β40 GuHCl |
Amyloid-β42 GuHCl |
|||||
r | P-value | r | P-value | r | P-value | r | P-value | |
ApoE TBS | −0.783 | 0.003 | −0.532 | 0.075 | −0.580 | 0.048 | −0.007 | 0.983 |
ApoE TX | −0.811 | 0.001 | −0.720 | 0.008 | −0.671 | 0.017 | −0.294 | 0.354 |
ApoE GuHCl | −0.713 | 0.009 | −0.657 | 0.020 | −0.518 | 0.085 | −0.140 | 0.665 |
APP | 0.217 | 0.499 | 0.664 | 0.019 | −0.014 | 0.966 | 0.832 | <0.001 |
APP-CTFβ | −0.126 | 0.697 | 0.406 | 0.191 | −0.322 | 0.308 | 0.783 | 0.003 |
BACE1 | −0.273 | 0.391 | −0.189 | 0.557 | −0.084 | 0.795 | 0.098 | 0.762 |
PSEN1 | 0.601 | 0.039 | 0.811 | 0.001 | 0.112 | 0.729 | 0.580 | 0.048 |
NEP | −0.245 | 0.443 | 0.028 | 0.931 | −0.469 | 0.125 | 0.035 | 0.914 |
IDE | 0.888 | <0.001 | 0.811 | 0.001 | 0.511 | 0.090 | 0.343 | 0.276 |
LRP1 | 0.622 | 0.031 | 0.804 | 0.002 | 0.315 | 0.319 | 0.692 | 0.013 |
LDLR | −0.266 | 0.404 | −0.357 | 0.255 | 0.084 | 0.795 | −0.266 | 0.404 |
GFAP | −0.951 | <0.001 | −0.615 | 0.033 | −0.608 | 0.036 | −0.028 | 0.931 |
SYP | 0.462 | 0.131 | 0.601 | 0.039 | 0.021 | 0.948 | 0.539 | 0.071 |
PSD95 | 0.755 | 0.005 | 0.923 | <0.001 | 0.350 | 0.265 | 0.706 | 0.010 |
Correlation coefficient (r) and P-value were acquired by the non-parametric Spearman rank test comparing median value of normalized levels of amyloid-β in the GuHCl fraction in cases with sporadic or familial Alzheimer’s disease with median value of normalized levels of molecules related to amyloid-β metabolism in normal ageing cases across 12 brain regions. Significant correlations are shown as bold text.